Concepedia

Improved Median Survival for Glioblastoma Multiforme Following Introduction of Adjuvant Temozolomide Chemotherapy

Michael Back, Emily LL Ang, Wai-Hoe Ng, Siew-Ju See, C. C. Tchoyoson Lim, SP Chan, Tseng-Tsai Yeo

Annals of the Academy of Medicine Singapore · 2007 · 28 citations · 16 references

Abstract

The median and 2-year survival outcomes are comparable to the results of the European Multicentre Study and justify the continued use of TMZ in routine clinical practice.

References

16

Radiotherapy plus Concomitant and Adjuvant Temozolomide for Glioblastoma

Roger Stupp, Warren Mason, Martin J. van den Bent et al. · New England Journal of Medicine · 2005 · 21K citations · Full text

<i>MGMT</i> Gene Silencing and Benefit from Temozolomide in Glioblastoma

Monika E. Hegi, Annie‐Claire Diserens, Thierry Gorlia et al. · New England Journal of Medicine · 2005 · 7.1K citations · Full text

A phase II study of temozolomide vs. procarbazine in patients with glioblastoma multiforme at first relapse

W.K. Alfred Yung, Robert E. Albright, Jeffrey J. Olson et al. · British Journal of Cancer · 2000 · 932 citations · Full text

Promising Survival for Patients With Newly Diagnosed Glioblastoma Multiforme Treated With Concomitant Radiation Plus Temozolomide Followed by Adjuvant Temozolomide

Roger Stupp, Pierre-Yves Dietrich, Sandrine Ostermann Kraljevic et al. · Journal of Clinical Oncology · 2002 · 812 citations

Survival following surgery and prognostic factors for recently diagnosed malignant glioma: data from the Glioma Outcomes Project

Edward R. Laws, Ian F. Parney, Wei Huang et al. · Journal of neurosurgery · 2003 · 660 citations